Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of Asian Flushing Syndrome With Topical Alpha Agonists

Trial Profile

Treatment of Asian Flushing Syndrome With Topical Alpha Agonists

Phase of Trial: Phase 0

Latest Information Update: 01 Nov 2018

At a glance

  • Drugs Brimonidine (Primary)
  • Indications Erythema; Flushing
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Oct 2018 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
    • 24 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Feb 2019.
    • 13 Jul 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top